lobbying_activities: 3048868
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3048868 | f3ac76c8-f393-49b1-8ae6-3242735382a9 | Q3 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2023 | third_quarter | MED | Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2023-10-13T10:52:44-04:00 |